Literature DB >> 23338904

Depressive symptoms, antidepressants and disability and future coronary heart disease and stroke events in older adults: the Three City Study.

Renaud Péquignot1, Christophe Tzourio, Karine Péres, Marie-Laure Ancellin, Marie-Cécile Perier, Pierre Ducimetière, Jean-Philippe Empana.   

Abstract

To investigate the association between baseline depressive symptoms and first fatal and non fatal coronary heart disease (CHD) and stroke in older adults, taking antidepressants and disability into account. In the Three City Study, a community-based prospective multicentric observational study cohort, 7,308 non-institutionalized men and women aged ≥65 years with no reported history of CHD, stroke or dementia, completed the 20-item Center for Epidemiologic Studies depression scale (CESD) questionnaire. First CHD and stroke events during follow-up were adjudicated by an independent expert committee. Hazard ratios (HRs) were estimated by Cox proportional hazard model. After a median follow-up of 5.3 years, 338 subjects had suffered a first non-fatal CHD or stroke event, and 82 had died from a CHD or stroke. After adjustment for study center, baseline socio-demographic characteristics, and conventional risk factors, depressive symptoms (CESD ≥ 16) were associated with fatal events only: fatal CHD plus stroke (HR = 2.50; 95% CI 1.57-3.97), fatal CHD alone (n = 57; HR = 2.21 ; 95%CI 1.27-3.87), and fatal stroke alone (n = 25; HR = 3.27; 95% CI 1.42-7.52). These associations were even stronger in depressed subjects receiving antidepressants (HR = 4.17; 95% CI 1.84-9.46) and in depressed subjects with impaired Instrumental Activities of Daily Living (HR = 8.93; 95% CI 4.60-17.34). By contrast, there was no significant association with non fatal events (HR for non-fatal CHD or stroke = 0.94; 95% CI 0.66-1.33). In non-institutionalized elderly subjects without overt CHD, stroke or dementia, depressive symptoms were selectively and robustly associated with first fatal CHD or stroke events.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23338904     DOI: 10.1007/s10654-013-9765-3

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  31 in total

1.  Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population.

Authors: 
Journal:  Neuroepidemiology       Date:  2003 Nov-Dec       Impact factor: 3.282

2.  Clinical depression and risk of out-of-hospital cardiac arrest.

Authors:  J P Empana; X Jouven; R N Lemaitre; N Sotoodehnia; T Rea; T E Raghunathan; G Simon; D S Siscovick
Journal:  Arch Intern Med       Date:  2006-01-23

3.  Cardiovascular events and mortality in newly and chronically depressed persons > 70 years of age.

Authors:  B W Penninx; J M Guralnik; C F Mendes de Leon; M Pahor; M Visser; M C Corti; R B Wallace
Journal:  Am J Cardiol       Date:  1998-04-15       Impact factor: 2.778

4.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies.

Authors:  Amanda Nicholson; Hannah Kuper; Harry Hemingway
Journal:  Eur Heart J       Date:  2006-11-02       Impact factor: 29.983

Review 5.  'Vascular depression' hypothesis.

Authors:  G S Alexopoulos; B S Meyers; R C Young; S Campbell; D Silbersweig; M Charlson
Journal:  Arch Gen Psychiatry       Date:  1997-10

6.  Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.

Authors:  Celine Straczek; Pierre Ducimetiere; Pascale Barberger-Gateau; Catherine Helmer; Karen Ritchie; Xavier Jouven; Laure Carcaillon; Philippe Amouyel; Christophe Tzourio; Jean-Philippe Empana
Journal:  J Am Geriatr Soc       Date:  2009-12-09       Impact factor: 5.562

7.  Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.

Authors:  Jordan W Smoller; Matthew Allison; Barbara B Cochrane; J David Curb; Roy H Perlis; Jennifer G Robinson; Milagros C Rosal; Nanette K Wenger; Sylvia Wassertheil-Smoller
Journal:  Arch Intern Med       Date:  2009-12-14

Review 8.  The epidemiology of depressive states in the elderly: implications for recognition, intervention and prevention.

Authors:  A F Jorm
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-03       Impact factor: 4.328

9.  Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study.

Authors:  Paul G Surtees; Nicholas W J Wainwright; Robert N Luben; Nicholas J Wareham; Sheila A Bingham; Kay-Tee Khaw
Journal:  Am J Psychiatry       Date:  2008-02-01       Impact factor: 18.112

10.  Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study.

Authors:  William Whang; Laura D Kubzansky; Ichiro Kawachi; Kathryn M Rexrode; Candyce H Kroenke; Robert J Glynn; Hasan Garan; Christine M Albert
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 27.203

View more
  10 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  The Generation R Study: Biobank update 2015.

Authors:  Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

Review 3.  Early origins of chronic obstructive lung diseases across the life course.

Authors:  Liesbeth Duijts; Irwin K Reiss; Guy Brusselle; Johan C de Jongste
Journal:  Eur J Epidemiol       Date:  2014-12-24       Impact factor: 8.082

4.  Cardiovascular disease risk in women with migraine.

Authors:  Fernanda Camboim Rockett; Alexandre da Silveira Perla; Ingrid D Schweigert Perry; Márcia L Fagundes Chaves
Journal:  J Headache Pain       Date:  2013-09-06       Impact factor: 7.277

Review 5.  Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies.

Authors:  Yong Gan; Yanhong Gong; Xinyue Tong; Huilian Sun; Yingjie Cong; Xiaoxin Dong; Yunxia Wang; Xing Xu; Xiaoxu Yin; Jian Deng; Liqing Li; Shiyi Cao; Zuxun Lu
Journal:  BMC Psychiatry       Date:  2014-12-24       Impact factor: 3.630

6.  Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis.

Authors:  Kristian Barlinn; Jessica Kepplinger; Volker Puetz; Ben M Illigens; Ulf Bodechtel; Timo Siepmann
Journal:  Neuropsychiatr Dis Treat       Date:  2014-12-18       Impact factor: 2.570

Review 7.  Antidepressants and cardiovascular adverse events: A narrative review.

Authors:  Mohammad Hassan Nezafati; Mohammad Vojdanparast; Pouya Nezafati
Journal:  ARYA Atheroscler       Date:  2015-09

8.  Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study.

Authors:  Hsiao-Ting Juang; Pei-Chun Chen; Kuo-Liong Chien
Journal:  BMC Neurol       Date:  2015-06-05       Impact factor: 2.474

9.  Depression increased risk of coronary heart disease: A meta-analysis of prospective cohort studies.

Authors:  Hongfu Cao; Hui Zhao; Li Shen
Journal:  Front Cardiovasc Med       Date:  2022-08-30

10.  Short-term aerobic exercise for depression in acute geriatric psychiatry: study protocol for a randomized controlled trial.

Authors:  Laura Elani Schulte; Tim Fleiner; Rieke Trumpf; Daria Wirtz; Thiemo Schnorr; Wiebren Zijlstra; Peter Haussermann
Journal:  Trials       Date:  2022-07-30       Impact factor: 2.728

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.